Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 17,990
-40 (-0.22%)
Sep 1, 2026, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 816.89 billion as of September 1, 2026. Its market cap has increased by 177.05% in one year.
Market Cap
816.89B
Enterprise Value
754.54B
Revenue
82.17B
Ranking
n/a
PE Ratio
33.68
Stock Price
17,990.00
ChartMarket Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 816.89B, an increase of 337.05%. That is a compound annual growth rate of 137.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 816.89B | -6.08% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 754.82B |
| Pharmicell | 673.25B |
| Komipharm International | 669.89B |
| Hyundai Bioscience | 631.13B |
| GI Innovation | 521.93B |
| AbClon | 519.75B |
| Medy-Tox | 463.40B |
| GC Corp. | 460.37B |